Alejandro Krolewiecki, MD discusses the path to regulatory approval, collaboration with global health organizations, and the role of partnerships in scaling up the new treatment for neglected tropical diseases.
Alejandro Krolewiecki, MD
Advertisement
Medical Officer specializing in Special Diseases, Internal Medicine, and Infectious Diseases, and Director of Innovation at Mundo Sano.
Articles by Alejandro Krolewiecki, MD
Alejandro Krolewiecki, MD, discussed testing a combination of albendazole and ivermectin to improve treatments for neglected tropical diseases.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
